UNSPSC 51262910: Bopindolol hydrogen malonate

This classification denotes an adrenergic beta-antagonist with the molecular formula C23H28N2O3.C3H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S3UWR70991, chemically known as propanedioic acid, compd. with (+/-)-2-((1,1-dimethylethyl)amino)-1-(((2-methyl-1h-indol-4-yl)oxy)methyl)ethyl benzoate (1:1), but more generally known as bopindolol hydrogen malonate, which bears US NIH Compound Identifier 636368.

European Medicines Agency schedules bopindolol hydrogen malonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05873MIG. Most nations, for tariff purposes, schedule bopindolol hydrogen malonate under HS 29339990. SMILES: CC1CC2C([NH]1)CCCC2OCC(CNC(C)(C)C)OC(=O)C3CCCCC3.C(C(=O)O)C(=O)O.

UNSPSC 51262910 Bopindolol hydrogen malonate is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local procurement activity under this code shows a substantial mismatch: the single documented opportunity is Seminole County, Florida's IFB for naloxone and drug deactivation systems, which is unrelated to bopindolol (a beta-blocker cardiovascular agent). The code as currently tagged in state and local systems does not reflect actual purchasing patterns in pharmaceutical procurement at the state and local level. Without additional documented opportunities under this code number, the taxonomy assignment appears to be either a data error or a placeholder tag that does not correlate to active procurement demand.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023 (a historical date that suggests the source contains outdated records). The contract included an initial two-year term with a one-year renewal option, fixed-fee pricing structure, and potential FEMA funding with associated federal compliance requirements. Vendors had to meet E-Verify certification, drug-free workplace standards, and specified insurance coverage thresholds. No other state or local jurisdictions appear in the available opportunities block, and no geographic concentration or repeat-buyer pattern emerges from this single, unrelated solicitation. If this code is intended to track bopindolol procurement specifically, state and local purchasing activity under it is not currently documented in active solicitations.